For best experience please turn on javascript and use a modern browser!
You are using a browser that is no longer supported by Microsoft. Please upgrade your browser. The site may not present itself correctly if you continue browsing.

Nazli Demirkaya investigates whether HIV-infected patients undergoing long-term combination antiretroviral treatment are still at risk of developing retinal neurodegeneration. Another iam is to detrmine the value of retinal thickness as a potential biomarker for brain alterations in HIV-infected patients.

Event details of Retinal biomarkers for HIV-related neurodegeneration
Date 29 May 2018
Time 10:00 -11:00
Location Agnietenkapel
Room Location

N. Demirkaya: In Search of Retinal Biomarkers for HIV Related Neurodegeneration: The AGEhIV and NOVICE Studies.


Prof. R.O. Schlingemann


Dr F.W.N.M. Wit

Dr F.D. Verbraak


Room Location

Oudezijds Voorburgwal 229 - 231
1012 EZ Amsterdam


This event is open to the public.